RXRX Financial Summary
Recursion Pharmaceuticals, Inc. key financial data and ratios.
Income Statement (Latest Annual)
- Revenue
- $74.7M
- Net Income
- -$644.8M
- EPS
- -1.44
TTM Ratios
- P/S
- 22.67
- P/B
- 1.76
- Current Ratio
- 5.50
Recursion Pharmaceuticals, Inc. key financial data and ratios.